MDMA

Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
VA Funds $1.5M MDMA Study To Treat PTSD In Veterans
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
VA Funds $1.5M MDMA Study To Treat PTSD In Veterans
Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential
Georgia Lawmakers Take First Steps Toward Psychedelic-Assisted Therapy For Veterans

MDMA Recent News

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.
PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial
PharmAla Biotech will supply GMP LaNeo MDMA to Mt. Sinai Health System for clinical research, advancing therapy for neurological disorders.
How Psychedelic Experiences Affect Couples: New Study Looks Into It
Imperial College London is recruiting couples for a study on how shared psychedelic experiences, such as MDMA, impact relationship intimacy, communication and satisfaction.
PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial
PharmAla Biotech will supply the University of Texas, San Antonio with a novel LaNeo MDMA dosage form for a clinical trial, advancing MDMA research and innovation.
PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial
PharmAla Biotech to supply MDMA for a clinical trial at Harvard's Maclean Hospital. Company also explores European distribution at CPHI Milan Conference.
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
A new study reveals how LSD, MDMA and d-amphetamine affect brain connectivity, offering insights into their distinct & shared mechanisms.
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
MAPS shifts focus to state-level MDMA therapy legalization after FDA denial, advocating for ballot measures in states like Colorado, Oregon, and Massachusetts.
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.
FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
The FDA rejected MDMA-assisted therapy for PTSD. SetSet's April Pride calls for harm-reduction education and regulatory change.
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science and UCL collaborate to refine MDMA-assisted therapy, addressing FDA concerns and enhancing psychotherapeutic practices for improved treatment outcomes.
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
MAPS funds a $200K pilot study at Emory University exploring the synergy between MDMA-assisted therapy and Massed Exposure Therapy for PTSD.
Cannabis And Psychedelics Industries: Summer's Over, Where Are We?
As summer fades, many of us reflect on its swift passage. For me, the season was a mix of joy and ongoing tasks after a lengthy construction project at our beach house. Similarly, the cannabis and psychedelics industries are grappling with their own extended “construction” phases.
Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows
New research reveals distinct cognitive effects of psychedelics and MDMA, showing that psychedelics may impair focus but boost creativity, while MDMA primarily disrupts memory.
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
FDA rejects MDMA for PTSD, delaying access to life-saving treatment though some states are introducing psychedelic therapy programs.
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
Bipartisan lawmakers and veterans push for FDA approval of MDMA therapy for PTSD, marking a milestone in mental health innovation.
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Explore how Healing Realty Trust is transforming psychedelic therapy through strategic real estate investments, paving the way for growth.
Psychedelics Therapy For Military Veterans In MA, Clinical Research Of Psilocybin In AZ And More
New Jersey Assembly members green-lighted an amendment to a psilocybin bill, to align its provisions with a Senate companion version from Senate President Nick Scutari (D) that was recently approved by the Senate Health, Human Services and Senior Citizens Committee in a 6–2.The members of the Massachusetts Senate passed a wide-ranging military veterans-focused measure that seeks to set up a working group tasked with studying and making recommendations around psilocybin and MDMA and their therapeutic benefits, among other things, reported Marijuana Moment.Clinical research firm Alira Health has teamed up with Scottsdale Research Institute (SRI) to provide regulatory and clinical support to bring clinical research on psilocybin to Arizona.
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.
VA Launches 'Psychedelic Charter,' California Dumps Weed Employment Protections For Some Law Enforcement Positions & More

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved